Genezen Collaborates with Elly's Team to Develop Innovative AAV Gene Therapy for Rare Neurodevelopmental Disorder Genezen partners with Elly's Team to accelerate AAV9 gene replacement therapy for NEDAMSS, a rare neurodevelopmental disorder, pushing boundaries in treatment innovation.

Genezen Collaborates with Elly's Team to Develop Innovative AAV Gene Therapy for Rare Neurodevelopmental Disorder #United_States #New_York #Genezen #Elly's_Team #AAV9_Therapy